Dr. Leilei Shi, Head of AIDD Platform at Nutshell Therapeutics, has over a decade of hands-on experience in artificial intelligence algorithms. He previously held senior positions at major technology companies including Ant Group and Microsoft, and led his team to win the First Prize of the CCF Science and Technology Progress Award. Dr. Shi possesses deep insights into and active exploration of AI applications in the pharmaceutical industry, with a strong focus on the practical business implementation and tangible value generation of AI within pipeline operations. Currently, he is responsible for AI platform development and pipeline project applications at Yudao Bio, and the corresponding pipeline assets have been advanced to the clinical trial stage.